MS&L appoints Peter Harris, Renee Wilson as new directors

Share this article:
MS&L has appointed Peter Harris to director of its corporate practice in North America, and Renee Wilson to managing director of its New York office.

In his newly created position, Harris will work with MS&L's other corporate practice directors to drive corporate strategy, leverage the agency's brand positioning, and expand the company's offerings. Part of Harris's focus, according to Sara Donaldson, a spokesperson for MS&L, will be on corporate health opportunities as they relate to reputational management, corporate social responsibility and product responsibility. “Peter's corporate practice provides reputation management and stakeholder relations support to several pharma companies, working closely with our national healthcare practice,” said Donaldson.

As managing director of MS&L's largest office, Wilson will work closely with Jim Tsokanos, president, North America, to manage client relationships and business development. Wilson will also oversee the New York office's 200 employees, and will be working more closely with the New York healthcare leaders and clients on strategic communications and innovative programs in this space, according to Donaldson. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.